跳至主要内容
临床试验/NCT01388868
NCT01388868已完成不适用

Determination of ED50 and ED95 of Vecuronium Infusion Dose for Maintaining Response of Train of Four Less Than 2 During the MEP Monitoring for Neurosurgery

Samsung Medical Center2 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2011年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
90
试验地点
2
主要终点
Amplitude of MEP monitoring

研究概览

简要总结

The maintenance of partial neuromuscular blocking during general anesthesia for neurosurgery is essential for intraoperative motor-evoked potential monitoring. However, the precise strategy of administering neuromuscular blocking agent for obtaining that goal has not been established. Therefore, the investigators tried to find the optimal initial dose of vecuronium infusion and determine the adequate goal of neuromuscular blocking as guided by neuromuscular transmission module (M-NMT Module, Datex-Ohmeda Inc, Helsinki, Finland).

详细描述

The maintenance of partial neuromuscular blocking during general anesthesia for neurosurgery is essential for intraoperative motor-evoked potential monitoring. However, the precise strategy of administering neuromuscular blocking agent for obtaining that goal has not been established. Therefore, the investigators tried to find the optimal initial dose of vecuronium infusion and determine the adequate goal of neuromuscular blocking as guided by neuromuscular transmission module (M-NMT Module, Datex-Ohmeda Inc, Helsinki, Finland). Previously, one to two counts of response to TOF stimulation has been considered to be primary goal of partial neuromuscular blocking needed for intraoperative motor evoked potential monitoring. However, the visualization of twitch height of response to TOF stimulation has been possible with the help of NMT module. For adequate motor evoked potential monitoring, twitch height of T1 or T2 is also as important as simple count of TOF stimulation. The investigators tried to establish a vecuronium infusion strategy as guided by not only count of TOF stimulation but also twitch height of T1 or T2.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult Patients undergoing neurosurgery with intraoperative motor evoked potential monitoring

排除标准

  • Patients who can not undergo motor evoked potential monitoring due to central or peripheral neuromuscular disease (e.g. Cerebral palsy, Myasthenia gravis, Acute spinal injury, neurologic shock)
  • Patients with hepatic or renal disease with altered metabolism of vecuronium
  • Patients with medication which influence the metabolism of vecuronium (e.g. calcium channel blocker, aminoglycoside antibiotics, Lithium, MgSO4)

结局指标

主要结局

Amplitude of MEP monitoring

时间窗: every 30 min during MEP monitoring

the value of MEP amplitude every 30 min during MEP monitoring

次要结局

  • latency of MEP monitoring(every 30 min during MEP monitoring)
  • Incidence of patient's spontaneous movement(from start to end of the MEP monitoring, an expected average of 4 hours)
  • Overall assessment of MEP monitoring quality(from start to end of the MEP monitoring, an expected average of 4 hours)
  • Incidence of patient's spontaneous respiration(from start to end of the MEP monitoring, an expected average of 4 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeong Jin Lee

Professor

Samsung Medical Center

研究点 (2)

Loading locations...

相似试验